The role of DYRK1A as a tau kinase in AD pathogenesis is well established; however, the effects of direct genetic DYRK1A manipulation in the brain and the underlying molecular mechanisms have not been fully demonstrated. This evidence concerns the gene DYRK1A and Alzheimer disease.